Generic drugmaker Aurobindo Pharma has received final approval from the U.S. Food and Drug Administration (U.S. FDA) to manufacture and market Rivaroxaban Tablets USP, 2.5 mg.The...
Cholamandalam Investment and Finance Company Ltd has recorded a consolidated profit after tax for the January-March 2025 quarter at ₹1,259.54 crore, the company said...